Google
ICCC — IMMUCELL CORPORATION (Healthcare >> Biotechnology)
ICCC FAQ
What is ICCC's P/E ratio?
IMMUCELL CORPORATION (ICCC) currently trades at a P/E ratio of 36.06.
What is ICCC's ROE?
IMMUCELL CORPORATION reports a Return on Equity (ROE) of -1.87%.
What is ICCC's dividend yield?
IMMUCELL CORPORATION offers a dividend yield of 0.00%.
What is ICCC's Deepscope Quality Score?
Deepscope rates ICCC's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ICCC?
Deepscope's AI Timing Score for ICCC is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ICCC belong to?
IMMUCELL CORPORATION is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 9.68
Price
-0.06
(-0.62%)
Day Change
|
|
|---|
ICCC, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 9.68 |
| PBV / Sector |
3.02 / 4.91
|
| Earning Per Share | -0.06 |
| PE / Sector |
36.06 / 18.34
|
| PEG or PE/Growth / Sector |
10.27 / 0.61
|
| Average 1M Daily Value |
0.32 M
GREAT
|
| Average 1W Daily Value |
0.18 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-13 11:13:00 |
| Symbol | ICCC |
| Name | IMMUCELL CORPORATION |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 9.05 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 88.12 / 9,034.83 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 56 Evergreen Drive, Portland, ME, United States, 04103
Phone: 207 878 2770
Website: https://immucell.com
Employees: 73
Sector: Healthcare >> Biotechnology
Description: ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
